NO20002343L - Procedure for potentiating intravenous estramustine phosphate - Google Patents

Procedure for potentiating intravenous estramustine phosphate

Info

Publication number
NO20002343L
NO20002343L NO20002343A NO20002343A NO20002343L NO 20002343 L NO20002343 L NO 20002343L NO 20002343 A NO20002343 A NO 20002343A NO 20002343 A NO20002343 A NO 20002343A NO 20002343 L NO20002343 L NO 20002343L
Authority
NO
Norway
Prior art keywords
potentiating
procedure
estramustine phosphate
intravenous estramustine
intravenous
Prior art date
Application number
NO20002343A
Other languages
Norwegian (no)
Other versions
NO20002343D0 (en
Inventor
Michael S Kopreski
Beryl Asp
Bo Fredholm
Per-Olav Gunnarsson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20002343D0 publication Critical patent/NO20002343D0/en
Publication of NO20002343L publication Critical patent/NO20002343L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20002343A 1998-03-27 2000-05-04 Procedure for potentiating intravenous estramustine phosphate NO20002343L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7954298P 1998-03-27 1998-03-27
PCT/US1999/004275 WO1999049869A1 (en) 1998-03-27 1999-03-26 Methods to potentiate intravenous estramustine phosphate

Publications (2)

Publication Number Publication Date
NO20002343D0 NO20002343D0 (en) 2000-05-04
NO20002343L true NO20002343L (en) 2000-05-04

Family

ID=22151209

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002343A NO20002343L (en) 1998-03-27 2000-05-04 Procedure for potentiating intravenous estramustine phosphate

Country Status (16)

Country Link
EP (1) EP1003521A4 (en)
JP (1) JP2001508810A (en)
KR (1) KR20010021656A (en)
CN (2) CN1636598A (en)
AU (1) AU750010B2 (en)
BR (1) BR9906425A (en)
CA (1) CA2295049A1 (en)
EA (1) EA004647B1 (en)
HU (1) HUP0200547A3 (en)
ID (1) ID24504A (en)
IL (1) IL133612A0 (en)
NO (1) NO20002343L (en)
NZ (1) NZ501987A (en)
PL (1) PL342969A1 (en)
WO (1) WO1999049869A1 (en)
ZA (1) ZA997821B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003201D0 (en) * 2000-02-11 2000-04-05 Pharmacia & Upjohn Spa Method to potentiate the therapeutic efficacy of taxane and derivatives thereof
US6436913B1 (en) * 2000-07-25 2002-08-20 Pharmacia & Upjohn Company Use of estramustine phosphate in the treatment of bone metastasis
RU2471511C1 (en) * 2011-05-04 2013-01-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНИОИ" Минздравсоцразвития России) Method of treating colonic liver metastases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS617292A (en) * 1984-06-20 1986-01-13 Japan Atom Energy Res Inst Method for producing an estracytic compound bound to an anticancer drug
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
MX9203808A (en) * 1987-03-05 1992-07-01 Liposome Co Inc HIGH DRUG CONTENT FORMULATIONS: LIPID, FROM LIPOSOMIC-ANTINEOPLASTIC AGENTS.
WO1993018751A1 (en) * 1992-03-23 1993-09-30 Georgetown University Liposome encapsulated taxol and a method of using the same
FR2697752B1 (en) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Antitumor compositions containing taxane derivatives.

Also Published As

Publication number Publication date
EA199901081A1 (en) 2000-12-25
WO1999049869A1 (en) 1999-10-07
CN1636598A (en) 2005-07-13
NO20002343D0 (en) 2000-05-04
BR9906425A (en) 2000-07-11
ID24504A (en) 2000-07-20
EP1003521A4 (en) 2003-07-23
EA004647B1 (en) 2004-06-24
ZA997821B (en) 2000-08-01
PL342969A1 (en) 2001-07-16
AU3353399A (en) 1999-10-18
HUP0200547A3 (en) 2003-07-28
AU750010B2 (en) 2002-07-11
IL133612A0 (en) 2001-04-30
CN1273530A (en) 2000-11-15
HUP0200547A2 (en) 2002-07-29
EP1003521A1 (en) 2000-05-31
KR20010021656A (en) 2001-03-15
CA2295049A1 (en) 1999-10-07
JP2001508810A (en) 2001-07-03
NZ501987A (en) 2002-10-25

Similar Documents

Publication Publication Date Title
NO991436D0 (en) The tieback connector
DE69933078D1 (en) Stent Aneurismic Treatment System
NO974554L (en) Procedure for the treatment of an underground formation
TR199800436A3 (en) The use of primidine derivatives for cancer prevention.
IS5949A (en) Adds useful bicyclic derivatives that help prevent cancer
BR9904281B1 (en) MEDICATION DISTRIBUTION ASSEMBLY
DE59903617D1 (en) patient connector
NO20010046D0 (en) Dolastatin-15 derivatives
NO20004849L (en) Offshoreborings system
FI980135A0 (en) Inbyggt system
DE69933079D1 (en) catheter
DE69921764D1 (en) CATHETER
DE69915677D1 (en) FORM SYSTEM
FI974493A0 (en) Arrangement of the hydraulic system
NO974972L (en) Procedure for preventing breast cancer
FR2776660B1 (en) DIAZEPINO-INDOLES OF PHOSPHODIESTERASES IV
DE50014156D1 (en) locking connection
DE69912327D1 (en) catheter
ATE276234T1 (en) UREA DERIVATIVES FOR PAIN FIGHTING
FR2761589B1 (en) CATHETER, ESPECIALLY FOR NEUROSURGERY
NO991088L (en) Self-locking coupling
TR199800403A3 (en) Method for the preparation of a-Bromo-lactam derivatives.
NO20002343L (en) Procedure for potentiating intravenous estramustine phosphate
PT1051172E (en) METHOD FOR TREATMENT OF THE DPCO
NO20005148D0 (en) Process for preparing 4-substituted-1H-indole-3-glyoxamides

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application